FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Watch: The Moment Fighter Bo Nickal Literally Jumped the Ring to Get to Trump, Say Words of Respect

Libs Try to Cancel Family-Friendly Comic Nate Bargatze for Trump Birthday Appearance: ‘Done with Him’

Alaska woman uses weapon to survive terrifying bear attack after predator mauls pooch: ‘I thought I was dead’

Son of Mango fashion billionaire heard tearfully telling 911 operator his father had ‘fallen down a ravine’

Vance Gives Perfect Response After ‘View’ Host Brings Up His Past Criticism of Trump

Republicans bat down bid to handcuff Trump’s war powers as peace deal nears

15 Antifa radicals indicted, 12 arrested in sweeping federal probe into Minneapolis anti-ICE operations

JD Vance Responds as Lindsey Graham Expresses Skepticism About Iran Deal

Trump’s Iran agreement raises a basic question: Is it actually a deal?

Blue state’s anti-ICE pledge collapses as GOP warns of new sanctuary ‘confederacy’

Mother’s tip helped unravel White House UFC drone plot: Affidavit

Lawmakers demand answers after NIH scientists charged in monkeypox smuggling conspiracy

MLB Reprimands Christian Players Who Took a Stand Against ‘Pride Night’

Todd Blanche earns attorney general bid endorsement from law enforcement alliance ahead of confirmation

Trump Says Israel Is Fighting ‘Too Long, and Too Many People Are Being Killed’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”